Drug Absorption in Bariatric Surgery Patients: A Narrative Review

Overview

Journal Health Sci Rep

Specialty General Medicine

Date 2022 May 5

PMID 35509385

Authors

Abdullah Abdulaziz Alalwan

Jeffrey Friedman

Osamah Alfayez

Abraham Hartzema

Affiliations

Soon will be listed here.

Abstract

Background: Despite the increase in the number of bariatric surgeries performed, little is known about the impact of the surgery on drug absorption. Unpredictability is assumed with drugs, given the anatomical changes after surgery.

Objective: To evaluate the impact of bariatric surgery on drug absorption based on the type of procedure performed.

Methods: We conducted a comprehensive literature review searching PubMed/Medline for published studies (from inception to December 2017) that evaluate the use of drugs and the assessment of drug absorption after bariatric surgery. Pharmacokinetic/pharmacodynamic studies, case reports, and observational studies were included in our review.

Results: We found 60 studies addressing drug use after bariatric surgery. Twenty-eight studies reported a decrease in drug absorption after bariatric surgery while only four studies showed an increase in drug absorption. Unchanged absorption of drugs was seen in 23 studies after the surgery.

Conclusion: The available information shows variations in drug absorption after bariatric surgery. The unpredictability may result from factors related to the patient, drug, and/or type of surgery. Therefore, pharmacists' involvement and close monitoring of patients after bariatric surgery could be effective to avoid sub-/supratherapeutic responses.

Citing Articles

Psychological and psychiatric standardized procedures for metabolic bariatric surgery: a clinical practice model for mental health providers.

Fausta M, Claudio C, Mario M, Emanuela P, Giuseppe N Updates Surg. 2024; .

PMID: 39644446 DOI: 10.1007/s13304-024-02053-5.

Molecular Mechanisms Affecting Statin Pharmacokinetics after Bariatric Surgery.

Petrinovic M, Majetic D, Bakula M, Pecin I, Fabris-Vitkovic D, Deskin M Int J Mol Sci. 2024; 25(19).

PMID: 39408705 PMC: 11476770. DOI: 10.3390/ijms251910375.

Varying concentrations of tyrosine kinase inhibitors in chronic myeloid leukemia patients following bariatric surgery: a case series.

Lau C, van Kesteren C, Cao Y, Smeenk R, Daenen L, Janssen J Ann Hematol. 2024; 103(11):4765-4771.

PMID: 39129028 PMC: 11534994. DOI: 10.1007/s00277-024-05924-4.

Reduced Bioavailability of Antidepressants for the Management of Generalized Anxiety Disorder Following Bariatric Surgery: A Case Study.

Schaefer M, Garrote F, Junquera P Cureus. 2024; 16(3):e56373.

PMID: 38633979 PMC: 11022812. DOI: 10.7759/cureus.56373.

Multiple micronutrient deficiencies as a long-term complication of bariatric surgery.

Dixit D, Rodriguez V, Naumann A, Kamel A BMJ Case Rep. 2023; 16(12).

PMID: 38061845 PMC: 10711813. DOI: 10.1136/bcr-2023-254775.

References

Peterson D, Zweig R . Absorption of anticonvulsants after jejunoileal bypass. Bull Los Angeles Neurol Soc. 1974; 39(2):51-5. View

Sobieraj D, Wang F, Kirton O . Warfarin resistance after total gastrectomy and Roux-en-Y esophagojejunostomy. Pharmacotherapy. 2008; 28(12):1537-41. DOI: 10.1592/phco.28.12.1537. View

Marzinke M, Petrides A, Steele K, Schweitzer M, Magnuson T, Reinblatt S . Decreased Escitalopram Concentrations Post-Roux-en-Y Gastric Bypass Surgery. Ther Drug Monit. 2015; 37(3):408-12. DOI: 10.1097/FTD.0000000000000146. View

Van Prooyen A, Hicks J, Lin E, Davis Jr S, Singh A, Harris D . Evaluation of An Inpatient Pharmacy Consult on Discharge Medications in Bariatric Surgery Patients. J Pharm Pract. 2021; 36(2):203-212. DOI: 10.1177/08971900211030238. View

Brill M, van Rongen A, van Dongen E, van Ramshorst B, Hazebroek E, Darwich A . The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery. Pharm Res. 2015; 32(12):3927-36. PMC: 4628089. DOI: 10.1007/s11095-015-1752-9. View

Azran C, Wolk O, Zur M, Fine-Shamir N, Shaked G, Czeiger D . Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations. Obes Rev. 2016; 17(11):1050-1066. DOI: 10.1111/obr.12434. View

Padwal R, Ben-Eltriki M, Wang X, Langkaas L, Sharma A, Birch D . Effect of gastric bypass surgery on azithromycin oral bioavailability. J Antimicrob Chemother. 2012; 67(9):2203-6. DOI: 10.1093/jac/dks177. View

Hamad G, Helsel J, Perel J, Kozak G, McShea M, Hughes C . The effect of gastric bypass on the pharmacokinetics of serotonin reuptake inhibitors. Am J Psychiatry. 2012; 169(3):256-63. PMC: 3583374. DOI: 10.1176/appi.ajp.2011.11050719. View

Padwal R, Gabr R, Sharma A, Langkaas L, Birch D, Karmali S . Effect of gastric bypass surgery on the absorption and bioavailability of metformin. Diabetes Care. 2011; 34(6):1295-300. PMC: 3114332. DOI: 10.2337/dc10-2140. View

10.

Abeles D, Shikora S . Bariatric surgery: current concepts and future directions. Aesthet Surg J. 2008; 28(1):79-84. DOI: 10.1016/j.asj.2007.09.007. View

11.

OBrien P, Dixon J, Laurie C, Skinner S, Proietto J, McNeil J . Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006; 144(9):625-33. DOI: 10.7326/0003-4819-144-9-200605020-00005. View

12.

Magee S, Shih G, Hume A . Malabsorption of oral antibiotics in pregnancy after gastric bypass surgery. J Am Board Fam Med. 2007; 20(3):310-3. DOI: 10.3122/jabfm.2007.03.060177. View

13.

Geraldo M, Fonseca F, Gouveia M, Feder D . The use of drugs in patients who have undergone bariatric surgery. Int J Gen Med. 2014; 7:219-24. PMC: 4026560. DOI: 10.2147/IJGM.S55332. View

14.

Higa K, Boone K, Ho T, Davies O . Laparoscopic Roux-en-Y gastric bypass for morbid obesity: technique and preliminary results of our first 400 patients. Arch Surg. 2000; 135(9):1029-33; discussion 1033-4. DOI: 10.1001/archsurg.135.9.1029. View

15.

Ablassmaier B, Klaua S, Jacobi C, Muller J . Laparoscopic gastric banding after heart transplantation. Obes Surg. 2002; 12(3):412-5. DOI: 10.1381/096089202321088273. View

16.

Abdulaziz Alalwan A, Friedman J, Alfayez O, Hartzema A . Drug absorption in bariatric surgery patients: A narrative review. Health Sci Rep. 2022; 5(3):e605. PMC: 9059175. DOI: 10.1002/hsr2.605. View

17.

Kennedy M, Wade D . Phenytoin absorption in patients with ileojejunal bypass. Br J Clin Pharmacol. 1979; 7(5):515-8. PMC: 1429578. DOI: 10.1111/j.1365-2125.1979.tb00996.x. View

18.

Kampmann J, Klein H, Lumholtz B, Molholm Hansen J . Ampicillin and propylthiouracil pharmacokinetics in intestinal bypass patients followed up to a year after operation. Clin Pharmacokinet. 1984; 9(2):168-76. DOI: 10.2165/00003088-198409020-00004. View

19.

Andersen A, LEBECH P, Sorensen T, Borggaard B . Sex hormone levels and intestinal absorption of estradiol and D-norgestrel in women following bypass surgery for morbid obesity. Int J Obes. 1982; 6(1):91-6. View

20.

Gerrits E, Ceulemans R, Van Hee R, Hendrickx L, Totte E . Contraceptive treatment after biliopancreatic diversion needs consensus. Obes Surg. 2003; 13(3):378-82. DOI: 10.1381/096089203765887697. View